Co-Authors
This is a "connection" page, showing publications co-authored by Sonia Gandhi and Charles Swanton.
Connection Strength
0.865
-
Misuse of SARS-CoV-2 testing in symptomatic health-care staff in the UK - Authors' reply. Lancet. 2020 10 24; 396(10259):1329-1330.
Score: 0.227
-
Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients. Lancet. 2021 09 18; 398(10305):1038-1041.
Score: 0.060
-
Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains. Elife. 2021 07 29; 10.
Score: 0.060
-
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC. Lancet. 2021 07 17; 398(10296):207-209.
Score: 0.060
-
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination. Lancet. 2021 06 19; 397(10292):2331-2333.
Score: 0.059
-
Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2. Nat Med. 2021 08; 27(8):1362-1366.
Score: 0.059
-
SARS-CoV-2 detection by a clinical diagnostic RT-LAMP assay. Wellcome Open Res. 2021; 6:9.
Score: 0.058
-
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science. 2020 12 11; 370(6522):1339-1343.
Score: 0.057
-
Clinical outcomes of COVID-19 in long-term care facilities for people with epilepsy. Epilepsy Behav. 2021 02; 115:107602.
Score: 0.057
-
Scalable and robust SARS-CoV-2 testing in an academic center. Nat Biotechnol. 2020 08; 38(8):927-931.
Score: 0.056
-
Author Correction: Scalable and robust SARS-CoV-2 testing in an academic center. Nat Biotechnol. 2020 08; 38(8):1000.
Score: 0.056
-
Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers. Lancet. 2020 07 25; 396(10246):e6-e7.
Score: 0.056